GlassScriptPhysician profile
Leslie Rogers
NPI 1134407489
$521.45
in general payments reported to CMS, 2019-2025
13 companies · $92.54 in 2025
The $92.54 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.04 · 2022: $56.53 · 2023: $171 · 2024: $164 · 2025: $92.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $120.59 | 2023-2025 | Belbuca, Xtampza |
| Nalu Medical, INC. | $72.27 | 2023 | Nalu Neurostimulation System |
| Abbvie INC. | $60.24 | 2024-2025 | |
| Si-Bone, INC. | $47.89 | 2024 | |
| Boston Scientific Corporation | $37.46 | 2021-2023 | G4 Rf Generator |
| Pfizer INC. | $35.26 | 2021-2024 | |
| Tonix Medicines, INC. | $27.79 | 2025 | Tonmya |
| Globus Medical, INC. | $24.73 | 2025 | Senza |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Horizon Therapeutics Plc | $20.69 | 2022 | |
| Lilly USA, LLC | $20.48 | 2023 | Emgality |
| Averitas Pharma INC. | $18.21 | 2024 | Qutenza |
| Medtronic, INC. | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.